You are currently not logged in to BMJ Careers.
  • Advert number: 301285-0
  • Posted Date: 26/04/12
  • Closing Date: 13/05/12


Consultant Clinical Oncologist Lung

6 Programmed Activities

The Royal Marsden NHS Foundation Trust is one of the leading cancer centres in the world and has an international reputation for the care and treatment it provides. The associated Institute of Cancer Research has a similar reputation for research and development. The partnership between the Royal Marsden Hospital and the Institute of Cancer Research constitutes a centre of excellence for research and development, education, treatment and care of cancer. Together they are acknowledged to be one of the largest comprehensive cancer centres in the world. The Royal Marsden serves a local, regional, national and international population from two hospital sites, Chelsea and Sutton. It is the designated Cancer Centre for the South West London Cancer Network and part of the London and South East Sarcoma Network.

The post has recognised the need to facilitate tumour site specialisation and to accommodate the ongoing increase in oncology activity identified over the last decade.

At Chelsea there are four Linacs, a CT scanner for simulation, a conventional simulator and the Brachytherapy service. This comprises an out-patient high dose rate (HDR) microselectron and iodine seed implantation of the prostate. Medium-term plans are for a two PDR systems in a ward-environment and continuation of the iodine seed service. MRI and CT image-based brachytherapy planning is being developed. A Cyberknife, one of the first in the UK, was commissioned in 2011 and offers SBRT for lung cancer patients.

The radiotherapy department at Sutton currently has seven Linacs, one superficial x-ray machine and two CT scanners for simulation. There is portal imaging on all Linacs and all are capable of IMRT. IGRT is available on both sites and is used in the research setting.

Applications are invited for a part time Consultant Clinical Oncologist specialising in lung cancer. You will hold an MRCP or equivalent qualification, CCT in clinical oncology and be eligible for full GMC registration.

You will provide additional cover for the lung radiotherapy service working in conjunction with two existing clinical oncology consultants and three medical oncologists. The post offers you an opportunity to develop the lung steroetactic radiotherapy service.

Please apply online via quoting reference 282-C0764AAC.

Closing date: 13 May 2012.

The Trust reserves the right to amend the closing date of job vacancies at any time.